Nori Toyosato Bracken

Cancer immunology and clinical toxicology with a focus on how the tumor microenvironment and epigenetic modifications influence immune system dynamics, leading to drug resistance and metastatic progression. Using both murine and patient-derived ex vivo tumors to generate 3D organoid cultures, I investigate genetic drivers of immune suppression. By integrating pharmacological and genomic approaches, we hope to determine mechanisms of resistance in cancer therapy, and biomarkers for clinical prognosis.

Mentor: Marcus Bosenberg